美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

國藥控股ADR

13.64

-0.1335-0.97%

成交量：15.07萬

成交額：207.96萬

市值：85.13億

市盈率：8.73

高：13.92

開：13.77

低：13.57

收：13.77

52周最高：14.13

52周最低：10.72

股本：6.24億

流通股本：2.68億

量比：4.02

換手率：0.06%

股息：0.49

股息率：3.61%

每股收益(TTM):1.56

每股收益(LYR):1.55

淨資產收益率：7.83%

總資產收益率：2.54%

市淨率：0.72

市盈率(LYR):8.81

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

國藥控股與天士力醫藥集團達成戰略合作共築「戰略一體化服務」生態新標杆

啱啱！國藥控股董事長正式官宣

122億！國藥控股大合作來了

中食药信息网

國藥控股（湖南）醫藥創新產業園即將投產

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/SHTDY"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"SHTDY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SHTDY\",,,,,undefined,":{"symbol":"SHTDY","market":"US","secType":"STK","nameCN":"國藥控股ADR","latestPrice":13.639,"timestamp":1770670800000,"preClose":13.7725,"halted":0,"volume":150711,"delay":15,"changeRate":-0.00969322926120904,"floatShares":268330371,"shares":624131238,"eps":1.563169,"marketStatus":"未開盤","change":-0.1335,"latestTime":"02-09 16:00:00 EST 延時","open":13.77,"high":13.92,"low":13.57,"amount":2079630.0413000006,"amplitude":0.025413,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":1.563169,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1770714000000},"marketStatusCode":0,"adr":0,"adrRate":5,"exchange":"PINK LIMITED","adjPreClose":13.7725,"volumeRatio":4.019968},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SHTDY\",,,,,undefined,":{"symbol":"SHTDY","floatShares":268330371,"roa":"2.54%","roe":"7.83%","lyrEps":1.547539,"volumeRatio":4.019968,"shares":624131238,"dividePrice":0.492048,"high":13.92,"amplitude":0.025413,"preClose":13.7725,"low":13.57,"week52Low":10.72,"pbRate":"0.72","psRate":"0.10","week52High":14.13,"institutionHeld":0,"latestPrice":13.639,"eps":1.563169,"divideRate":0.036077,"volume":150711,"delay":15,"ttmEps":1.563169,"open":13.77,"prevYearClose":12.4,"prevWeekClose":13.7725,"prevMonthClose":13.3,"prevQuarterClose":12.4,"fiveDayClose":13.34,"twentyDayClose":13.3,"sixtyDayClose":13.44},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SHTDY\",params:#limit:5,,,undefined,":[{"date":"2025-06-17","symbol":"SHTDY","amount":0.471279,"announcedDate":"2025-05-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-17","defaultRemindTime":1750167000000,"name":"国药控股ADR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-08-27","payableDate":"2025-06-17","currency":"USD","dateTimestamp":1750132800000,"payDate":"2025-08-27"},{"market":"US","date":"2024-08-22","symbol":"SHTDY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1724299200000,"reportTimeType":"post","actualEps":null},{"date":"2024-06-18","symbol":"SHTDY","amount":0.6011,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-18","defaultRemindTime":1718717400000,"name":"国药控股ADR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-08-28","payableDate":"2024-06-18","currency":"USD","dateTimestamp":1718683200000,"payDate":"2024-08-28"},{"market":"US","date":"2024-04-25","symbol":"SHTDY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1714017600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-03-21","symbol":"SHTDY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1710993600000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SHTDY\",market:\"US\",,,undefined,":[{"executeDate":"2016-06-17","recordDate":"2016-06-21","paymentDate":"2016-08-30","value":0.246246,"currency":"USD"},{"executeDate":"2019-07-01","recordDate":"2019-07-02","paymentDate":"2019-09-11","value":0.347513,"currency":"USD"},{"executeDate":"2020-06-12","recordDate":"2020-06-15","paymentDate":"2020-08-26","value":0.333835,"currency":"USD"},{"executeDate":"2021-06-14","recordDate":"2021-06-15","paymentDate":"2021-08-25","value":0.427193,"currency":"USD"},{"executeDate":"2022-06-24","recordDate":"2022-06-27","paymentDate":null,"value":0.480451,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SHTDY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2353,"buy":0.4118,"hold":0.3529,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4118,"analysts":17,"updateTime":1767762000000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SHTDY\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2594266579","title":"國藥控股與天士力醫藥集團達成戰略合作 共築「戰略一體化服務」生態新標杆","url":"https://stock-news.laohu8.com/highlight/detail?id=2594266579","media":"国药控股","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594266579?lang=zh_tw&edition=fundamental","pubTime":"2025-12-25 20:50","pubTimestamp":1766667043,"startTime":"0","endTime":"0","summary":"近日，国药控股与天士力医药集团举行战略合作沟通会。国药控股副总裁胡立刚，天士力医药党委书记、董事长周辉出席并见证签约。国药控股所属35家子公司负责人，天士力医药集团团队负责人共同参会。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225215126a6cee6e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225215126a6cee6e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SHTDY","BK4175"],"gpt_icon":0},{"id":"2593348927","title":"啱啱！國藥控股董事長正式官宣","url":"https://stock-news.laohu8.com/highlight/detail?id=2593348927","media":"制药在线","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593348927?lang=zh_tw&edition=fundamental","pubTime":"2025-12-22 13:39","pubTimestamp":1766381987,"startTime":"0","endTime":"0","summary":"国药控股董事长职位调整尘埃落定。国药控股换帅落定同步更新董事名单12月19日，随着国药控股股东特别大会的召开，国药控股此前提名的国药系老将晋斌正式出任董事长。目前，国药控股最新董事名单已同步更新，具体角色与职能如下：营收承压亟待破局已开启多项合作目前来看，晋斌上任之际，国药控股正面临持续的营收增长压力。强强合作成为国药控股扭转营收颓势的方式之一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222133956a6bff438&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222133956a6bff438&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SHTDY","BK4175"],"gpt_icon":0},{"id":"2589866834","title":"122億！國藥控股大合作來了","url":"https://stock-news.laohu8.com/highlight/detail?id=2589866834","media":"中食药信息网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589866834?lang=zh_tw&edition=fundamental","pubTime":"2025-12-04 21:35","pubTimestamp":1764855320,"startTime":"0","endTime":"0","summary":"免费领取10学时视频课程中食药智慧教育管理平台2025年12月03日，复宏汉霖消息称，将重续与国药控股经销合作，合作期限为2026年1月1日至2028年12月31日。2023年-2025年9月，国药控股分别完成了19.17亿元、20.40亿元以及16.93亿元的销售额。在此背景下，国药控股与复宏汉霖再次达成合作，未来三年的产品销售总额上限高达122.24亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205021829a4cd1d17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205021829a4cd1d17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4175","SHTDY"],"gpt_icon":0},{"id":"2589834850","title":"國藥控股（湖南）醫藥創新產業園即將投產","url":"https://stock-news.laohu8.com/highlight/detail?id=2589834850","media":"红网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589834850?lang=zh_tw&edition=fundamental","pubTime":"2025-12-04 16:49","pubTimestamp":1764838153,"startTime":"0","endTime":"0","summary":"国药控股（湖南）医药创新产业园作为国药控股湖南有限公司布局医药健康供应链的重点项目，国药控股（湖南）医药创新产业园于2024年4月正式开工建设，核心定位为现代化、智慧化医药健康产业供应链枢纽与服务平台，建成后将进一步完善区域医药供应链体系，提升公共卫生应急保障能力。相较于一期项目，国药控股（湖南）医药创新产业园在功能升级、技术应用、服务效能上实现质的飞跃。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204165227a72362b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204165227a72362b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SHTDY","BK4175"],"gpt_icon":0}],"pageSize":4,"totalPage":7,"pageCount":1,"totalSize":26,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/SHTDY\",params:#limit:6,delay:false,,,undefined,":[]}}